Hemogenyx Pharmaceuticals (HEMO)

Sector:

Pharma and Biotech

700.50p
   
  • Change Today:
      50.50p
  • 52 Week High: 1,290.00
  • 52 Week Low: 412.50
  • Currency: UK Pounds
  • Shares Issued: 6.90m
  • Volume: 25,190
  • Market Cap: £48.31m
  • RiskGrade: 340
  • Beta: 0.01

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Alexis M. Sandler 187,727 £1,315,028
Vladislav Sandler Ph.D. 103,862 £727,553
Peter Redmond 13,991 £98,007

Major Shareholders

Notifier** Holding Value*
David John Smith 416,530 £2,917,793
Alexis Sandler 187,726 £1,315,021
Dr Vladislav Sandler 103,862 £727,553
Optiva Securities Limited 70,329 £492,655
Flascherberg Capital Anstalt 69,991 £490,287
Craig Auringer 59,593 £417,449
HSBC Client Holdings Nominee (UK) Limited 45,160 £316,346
Ron Valk 42,828 £300,010
Samantha Bauer 42,706 £299,156
Plum Capital 29,232 £204,770
43 North LLC 28,429 £199,145
Abdelatif LACHAB 6,500 £45,532
Wayne Gibson 6,500 £45,532

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HEMO Market Data

Currency UK Pounds
Share Price 700.50p
Change Today 50.50p
% Change 7.77 %
52 Week High 1,290.00
52 Week Low 412.50
Volume 25,190
Shares Issued 6.90m
Market Cap £48.31m
Beta 0.01
RiskGrade 340

HEMO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
66.09% below the market average66.09% below the market average66.09% below the market average66.09% below the market average66.09% below the market average
89.47% below the sector average89.47% below the sector average89.47% below the sector average89.47% below the sector average89.47% below the sector average
Price Trend
66.16% above the market average66.16% above the market average66.16% above the market average66.16% above the market average66.16% above the market average
90.70% above the sector average90.70% above the sector average90.70% above the sector average90.70% above the sector average90.70% above the sector average
Income Not Available
Growth Not Available

HEMO Dividends

No dividends found

Trades for 05-Oct-2026

Time Volume / Share Price
08:57 12 @ 750.00p
08:57 1 @ 750.00p
08:55 12 @ 750.00p
08:52 70 @ 709.78p
08:51 500 @ 666.67p

HEMO Key Personnel

CEO Vladislav Sandler Ph.D.

Top of Page